GlassScriptPhysician profile
Diane M Gronski
NPI 1689624629
$98,320.27
in general payments reported to CMS, 2019-2025
80 companies · $2,459 in 2025
The $2,459 reported for 2025 was more than what 80% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $21K · 2021: $34K · 2022: $20K · 2023: $2,879 · 2024: $3,270 · 2025: $2,459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,398 · Consulting Fee: $175 · Education: $35.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,398.11 |
| Consulting Fee | $175.00 |
| Education | $35.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $36,773.40 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Sanofi-Aventis U.S. LLC | $21,364.11 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $13,491.94 | 2021-2025 | |
| Abbott Laboratories | $10,541.92 | 2019-2025 | Proclaim |
| Novo Nordisk INC | $4,529.48 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $2,480.52 | 2019-2025 | Evenity, Prolia, Prolia |
| Abbvie INC. | $1,336.73 | 2019-2025 | |
| Medtronic, INC. | $858.90 | 2021-2025 | Minimed 780g, Intellis Adaptivestim, Micra |
| Lilly USA, LLC | $630.29 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $486.60 | 2019-2025 | Xifaxan, Trulance |
| Radius Health, INC. | $465.42 | 2019-2025 | Tymlos |
| Edwards Lifesciences Corporation | $371.16 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Corcept Therapeutics | $349.84 | 2020-2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $301.97 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Nestle Healthcare Nutrition INC. | $280.39 | 2021-2022 |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $227.64 | 2019-2024 | Omnipod |
| Recordati_rare_diseases_inc. | $223.15 | 2023-2025 | Isturisa, Signifor Lar |
| Amarin Pharma, INC. | $222.55 | 2019-2022 | |
| Boston Scientific Corporation | $205.62 | 2019-2025 | Superion Indirect Decompression System, Watchman Flx |
| Echosens North America, INC. | $198.41 | 2023 | Fibroscan |
| Daiichi Sankyo INC. | $196.09 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $160.95 | 2020-2025 | Belsomra, Steglatro, Capvaxive |
| Biohaven Pharmaceutical Holding Company LTD. | $159.61 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $158.59 | 2021 | |
| Grt US Holding, INC. | $109.23 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $108.61 | 2021-2023 | Trintellix |
| Aimmune Therapeutics, INC. | $101.72 | 2024-2025 | Zenpep |
| Teva Pharmaceuticals USA, INC. | $95.88 | 2020-2024 | Austedo Xr, Ajovy |
| Kowa Pharmaceuticals America, INC. | $95.69 | 2019-2023 | Livalo |
| Hologic Sales and Service, LLC | $90.66 | 2019-2024 | Aptima |
| Dexcom, INC. | $87.61 | 2022-2024 | Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $84.43 | 2020-2024 | Nexletol |
| Glaxosmithkline, LLC. | $82.65 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Kyowa Kirin, INC. | $80.89 | 2024-2025 | Crysvita |
| Exact Sciences Corporation | $80.22 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $69.60 | 2021-2025 | |
| Chiesi USA, INC. | $63.90 | 2024-2025 | Mycapssa |
| Janssen Pharmaceuticals, INC | $62.93 | 2019-2021 | |
| Lucid Diagnostics INC. | $57.97 | 2022-2023 | |
| Currax Pharmaceuticals LLC | $56.48 | 2020-2023 | Contrave, Nexlizet, Nexletol |
| Topcon Healthcare Solutions, INC. | $55.02 | 2019 | |
| Horizon Therapeutics Plc | $54.51 | 2021-2023 | Tepezza |
| Xeris Pharmaceuticals, INC. | $53.66 | 2022-2023 | Gvoke Hypopen, Recorlev |
| Cleerly, INC. | $52.74 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Amryt Pharma Holdings LTD | $49.09 | 2023 | Mycapssa |
| Otsuka America Pharmaceutical, INC. | $39.17 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $37.01 | 2022-2023 | Quviviq |
| Cequr Corporation | $36.64 | 2023-2025 | Cequr Simplicity |
| Ultragenyx Pharmaceutical INC. | $33.95 | 2020-2021 | |
| Eisai INC. | $28.93 | 2021 | |
| Sandoz INC. | $27.22 | 2025 | |
| Medtronic Minimed, INC. | $26.98 | 2019-2020 | |
| Nalpropion Pharmaceuticals LLC | $26.53 | 2019 | |
| Ascendis Pharma Endocrinology INC | $24.67 | 2025 | Yorvipath |
| Inspire Medical Systems, INC. | $24.58 | 2024 | Inspire |
| Mayne Pharma Commercial LLC | $23.61 | 2023 | |
| Biotronik Nro, INC. | $22.23 | 2023 | Biotronik |
| Sun Pharmaceutical Industries INC. | $21.37 | 2021 | |
| Lifescan, INC. | $21.03 | 2020 | |
| Intuitive Surgical, INC. | $19.98 | 2019 | |
| Sumitomo Pharma America, INC. | $19.37 | 2025 | Gemtesa |
| Impel Pharmaceuticals INC. | $18.67 | 2022 | |
| Alexion Pharmaceuticals, INC. | $18.49 | 2022 | |
| Ascensia Diabetes Care US INC. | $17.39 | 2024 | |
| Nalu Medical, INC. | $17.06 | 2021 | |
| Axsome Therapeutics, INC. | $15.48 | 2024 | Auvelity |
| Tolmar, INC. | $15.33 | 2025 | Jatenzo |
| Phadia US INC. | $15.19 | 2022 | |
| Impulse Dynamics (USA) INC. | $14.94 | 2024 | Optimizer |
| Mylan Pharmaceuticals INC. | $14.73 | 2021 | |
| Ibsa Pharma INC. | $14.23 | 2023 | Tirosint, Licart |
| Sequel Med Tech, LLC | $13.98 | 2025 | Twiist |
| Depuy Synthes Sales INC. | $13.68 | 2019 | |
| Valeritas, INC. | $13.64 | 2019 | |
| Amneal Pharmaceuticals LLC | $13.55 | 2024 | Unithroid |
| Nuvasive, INC. | $13.31 | 2021 | |
| Medtronic Vascular, INC. | $12.99 | 2019 | |
| Allergan, INC. | $12.88 | 2019 | |
| Lupin INC. | $11.39 | 2021 | |
| Therapeuticsmd, INC. | $11.30 | 2020 |
Drugs and devices associated with these payments
Farxiga $758Wegovy $648Evenity $627Prolia $571Minimed 780g $545Ozempic $539Kerendia $439Breztri $343Rybelsus $327Tymlos $266Korlym $262Airsupra $228Ubrelvy $226Xifaxan $224Isturisa $223Fibroscan $198Edwards Sapien 3 Transcatheter Heart Valve (Thv) $188Jardiance $182Sapien 3 Ultra Resilia $162Intellis Adaptivestim $152Mounjaro $140Tzield $125Synthroid $120Repatha $114Mycapssa $113Superion Indirect Decompression System $112Signifor Lar $110Trulance $104Zenpep $102Zepbound $92.16Otezla $88.19Crysvita $80.89Dexcom G6 Transmitter $72.47Omnipod $71.08Krystexxa $65.77Cologuard Collection Kit $62.74Qulipta $58.12Cleerly Labs $52.74Cleerly Ischemia $52.74Tepezza $49.02Aptima $48.40Contrave $43.04Proclaim $42.97Trelegy Ellipta $42.43Cequr Simplicity $36.64Paxlovid $36.02Tradjenta $34.95Austedo Xr $34.48Optimizer $29.88Ajovy $28.99Vraylar $28.85Tirosint $28.46Nexletol $27.78Arexvy $27.30Yorvipath $24.67Inspire $24.58Biotronik $22.23Emgality $22.21Watchman Flx $21.82Synjardy $20.97Gvoke Hypopen $20.90Gemtesa $19.37Shingrix $19.23Recorlev $17.87The Cologuard Plus Collection Kit $17.48Eversense E3 Sensor Kit - Retail $17.39Steglatro $16.85Belsomra $16.85Trintellix $16.68Quviviq $16.18Auvelity $15.48Livalo $15.47Jatenzo $15.33Linzess $15.16Micra $15.02Capvaxive $15.02Licart $14.23Twiist $13.98Nexlizet $13.75Unithroid $13.55Minimed 770g $12.88Soliqua 100/33 $12.80Toujeo $12.42Amyvid $10.34Kisunla $10.34
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Gronski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.